Herd Immunity and Pathogen Mutation
- Herd immunity relies on close exposure and genetic/background factors for natural infection.
- If a pathogen mutates, herd immunity may no longer be effective.
- The level of natural immunity can vary among individuals.
Antibody Titer in Serum: Principle of Vaccine
- Antibody titer in serum is a way to measure the immune response, which the vaccine takes advantage of.
Primary Response
- Upon the initial encounter with an antigen:
- Activated B cells, called plasma cells, produce IgM specific to that antigen.
- Subsequently, IgG specific to the antigen is also produced by the same plasma cells through class switching.
Secondary Response
- Upon the second encounter with the same antigen:
- Antibody titer increases more drastically.
- The peak response is reached in a shorter amount of time (between 2-7 days).
- Secondary response is mediated by memory B cells:
- A subset of activated B-cells that did not become plasma cells.
- These cells are long-lived (up to decades).
- Memory B cells undergo rapid clonal expansion upon encountering the same antigen.
- This produces more rapid and stronger protection, which is the basis for vaccine effectiveness.
Antibody timeline
* Initial exposure to antigen.
* IgM production begins around day 7, followed by IgG production.
* Second exposure to antigen on day 52.
* Rapid increase in IgG production, while IgM levels remain relatively low. Peak response between 58-65 days.